These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17942925)

  • 1. Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.
    Liang Y; Besch-Williford C; Brekken RA; Hyder SM
    Cancer Res; 2007 Oct; 67(20):9929-36. PubMed ID: 17942925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
    Hyder SM; Murthy L; Stancel GM
    Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors.
    Mafuvadze B; Liang Y; Besch-Williford C; Zhang X; Hyder SM
    Horm Cancer; 2012 Aug; 3(4):160-71. PubMed ID: 22569706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells.
    Liang Y; Besch-Williford C; Benakanakere I; Hyder SM
    Int J Oncol; 2007 Oct; 31(4):777-84. PubMed ID: 17786308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study.
    Benakanakere I; Besch-Williford C; Ellersieck MR; Hyder SM
    Endocr Relat Cancer; 2009 Mar; 16(1):85-98. PubMed ID: 19075036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells.
    Carroll CE; Ellersieck MR; Hyder SM
    Menopause; 2008; 15(3):570-4. PubMed ID: 18467956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects.
    Liang Y; Hyder SM
    Endocrinology; 2005 Aug; 146(8):3632-41. PubMed ID: 15845615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
    Wu J; Brandt S; Hyder SM
    Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors.
    Liang Y; Besch-Williford C; Benakanakere I; Thorpe PE; Hyder SM
    Breast Cancer Res Treat; 2011 Jan; 125(2):407-20. PubMed ID: 20349129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
    Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.
    Hyder SM; Chiappetta C; Stancel GM
    Int J Cancer; 2001 May; 92(4):469-73. PubMed ID: 11304678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells.
    Hyder SM; Liang Y; Wu J; Welbern V
    Endocr Relat Cancer; 2009 Sep; 16(3):809-17. PubMed ID: 19570906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
    Wu J; Richer J; Horwitz KB; Hyder SM
    Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice.
    Liang Y; Benakanakere I; Besch-Williford C; Hyder RS; Ellersieck MR; Hyder SM
    Menopause; 2010; 17(5):1040-7. PubMed ID: 20461021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development.
    Carroll CE; Liang Y; Benakanakere I; Besch-Williford C; Hyder SM
    Int J Oncol; 2013 Jan; 42(1):179-87. PubMed ID: 23123638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts.
    Cook MT; Liang Y; Besch-Williford C; Goyette S; Mafuvadze B; Hyder SM
    Springerplus; 2015; 4():444. PubMed ID: 26312209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.